The current valuation score of Sanara Medtech Inc is 8.47, ranking 56 out of 155 in the Pharmaceuticals industry. Its current P/E ratio is -8.70, which is -56.89% below the recent high of -3.75 and -874.45% above the recent low of -84.78.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.